IVZ · available-data snapshot
Invesco Ltd. (IVZ): Available-Data Snapshot
TickerWorth does not publish a DCF fair value for Invesco Ltd. (IVZ); the reason is set out below. What its filings and market data do show is below. The snapshot also sets out its trading multiples against 5 peers. Snapshot as of Oct 19, 2026.
Model by Miraaj Patel · generated from public market data · Updated Oct 19, 2026 · How these pages are made
Why is there no fair value for IVZ?
We do not publish a fair value for Invesco Ltd.. What we can say from its filings and market data is below.
What is IVZ's TickerWorth Score?
Cheap against our estimate — but a weaker business
Compared with Financial Services companies in US
Its strongest point: trades below our estimate of what it's worth. Its weakest: profitability is weak.
our cash-flow model doesn't fit this business, so we won't award our top grade off the remaining lenses
- Value · 77 of 100
Cheaper than 77% of Financial Services companies in US
- Price vs worth · 100 of 100
- Quality · 16 of 100
More profitable than 16% of Financial Services companies in US
- Financial health · 49 of 100
Financially stronger than 49% of Financial Services companies in US
- Growth · 83 of 100
Growing faster than 83% of Financial Services companies in US
- Momentum · 60 of 100
Outperformed 60% of Financial Services companies in US over the past year
Confidence: Medium confidence · Scored
Get the Undervalued Company of the Week.
- Price
- $28.41
- Market cap
- $12,
545, 216, 512 - 52-week high
- $33.66
- 52-week low
- $20.67
- Currency
- USD
- Exchange
- NYSE
Snapshot of Oct 19, 2026, quote time not published · Prices are delayed.
What we can say
We don't publish a discounted-cash-flow fair value for Invesco Ltd. (IVZ) because the free data sources we rely on don't expose the multi-year financials a DCF needs — common for small or thinly-covered listings. Rather than invent numbers, this page shows an honest snapshot of what the public data does support: the current price and size, any relative valuation multiples that exist, a book-value view, and a price-based read. Treat it as a descriptive starting point, not a valuation and not investment advice.
Read the full reasoning
On the numbers we do have, IVZ trades at a recent price of $28.41, a market capitalisation of about $12,545,216,512, sitting 60% of the way up its 52-week range ($20.67–$33.66), on the NYSE.
The standard alternative to a DCF is relative valuation — comparing IVZ's trading multiples against a sector benchmark. Here that gives Fwd P/E of 8.7× (cheaper than the peer median of 13.3×); P/B of 1.3× (cheaper than the peer median of 2.6×); P/S of 1.8× (cheaper than the peer median of 4.7×); EV/EBITDA of 11.5× (cheaper than the peer median of 24.5×); Dividend yield of 3.0% (cheaper than the peer median of 1.9%). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.
The asset, or book-value, lens is the classic tool for asset-heavy businesses and financials. IVZ shows a price-to-book (P/B) of 1.26 and book value of $22.56 per share. Price-to-book compares the market price to the accounting net-asset value per share; below 1.0 can mean a discount to net assets or that the market is pricing in trouble — descriptive either way, never a buy signal on its own.
Finally, a price-based read — explicitly not a valuation. IVZ is in a mixed trend, trading -15.6% from its 52-week high. Over the past year the stock is +23.5%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.
IVZ vs peers
Sector benchmark (bellwethers, not direct competitors).
| Multiple | IVZ | Peer median | Read |
|---|---|---|---|
| Fwd P/E | 8.7× | 13.3× | cheaper than |
| P/B | 1.3× | 2.6× | cheaper than |
| P/S | 1.8× | 4.7× | cheaper than |
| EV/EBITDA | 11.5× | 24.5× | cheaper than |
| Dividend yield | 3.0% | 1.9% | cheaper than |
What does Invesco Ltd. do?
What does it do?
Invesco Ltd. is a publicly owned investment manager. It operates in the Asset Management industry (Financial Services sector), headquartered in United States. The company employs roughly 7,405 people.
How does it make money?
The business turns $6.9B in annual revenue into profit. Out of every $100 of sales, about $20 is left as operating profit (operating margin of 20.0%), after a 30% gross margin on the products/services it sells. After all costs, taxes and interest, -0.9% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks mixed: carries modest debt (0.1× equity), may struggle to cover its short-term bills (0.7× current ratio), and is currently lossmaking.
Who at IVZ filed insider trades?
| Date | Insider | Relationship | What happened | Value | Filing |
|---|---|---|---|---|---|
| Invesco Advisers, Inc. | Director | Grant / award | $460,877.75 | Form 4 for Invesco Advisers, Inc. (opens sec.gov in a new tab) | |
| Invesco Advisers, Inc. | Director | Disposition to issuer | $255,548.48 | Form 4 for Invesco Advisers, Inc. (opens sec.gov in a new tab) | |
| WOOD PHOEBE A | Director | Open-market sale | $97,320.00 | Form 4 for WOOD PHOEBE A (opens sec.gov in a new tab) | |
| Lo Andrew Tak Shing | Senior Managing Director | Open-market sale | $3,247,048.00 | Form 4 for Lo Andrew Tak Shing (opens sec.gov in a new tab) | |
| Butcher Stephanie | Senior Managing Director | Open-market sale | $1,455,779.34 | Form 4 for Butcher Stephanie (opens sec.gov in a new tab) | |
| Lo Andrew Tak Shing | Senior Managing Director | Open-market sale | $1,396,897.85 | Form 4 for Lo Andrew Tak Shing (opens sec.gov in a new tab) |
A disclosure, not a signal to trade. Source: SEC EDGAR (Form 4). Older filings and the 90-day buying-and-selling read are part of Pro. See plans
Companies we do put a number on
Not investment advice. TickerWorth Score is a model output.
A descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public market data that can be wrong, stale or incomplete.